Biolyzr Aps: Financial statements 2023
CVR: 42991910
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Biolyzr Aps (CVR 42991910) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,133,312 and a net result of DKK 729,253 compared with DKK 5,552 the year before. That is an increase of 15,602.3% compared with the year before. Equity in the 2023 report amounted to DKK 774,806. The solvency ratio was 60.3%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,133,312
- Profit/Loss
- DKK 729,253
- Equity
- DKK 774,806
- Total Assets
- DKK 1,285,883
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 2.1 mio. | 729 t. | 775 t. | 2 |
| 2022 | - | 14 t. | 6 t. | 46 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Biolyzr Aps has published its annual report for 2022. Gross profit came to DKK 13,586, and the net result was DKK 5,552.
About Biolyzr Aps
Biolyzr Aps is a Danish company of the type Anpartsselskab based in Værløse, founded in 2022. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Michael Fjording Consult ApS. The management consists of Marianne Scheel Fjording and Michael Fjording. The company is owned by Michael Fjording. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,654,350 and a net result of DKK 1,244,827 compared with DKK 1,796,043 the year before. Equity in the 2025 report amounted to DKK 3,648,695.